In furtherance to the Board Meeting Notice dated 01st August 2022, we wish to inform you that at the meeting of Board of Directors of M/s Phyto Chem (India) Ltd. held today i.e., on 08th August 2022, the Board has inter-alia considered and approved the Unaudited Financial results for the First Quarter ended 30th June 2022. The said Unaudited Financial Results were reviewed by the Audit Committee and thereafter approved by the Board. Pursuant to Regulation 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, statement showing the Unaudited Financial Results for the First Quarter ended on 30th June 2022 along with the Limited Review Report issued by the Statutory Auditors is attached herewith. The meeting commenced at 04:30 P.M. and concluded at 06:45 P.M. This is for your information and record

Pursuant to the provisions of Regulation 30(6) of the SEBI (LODR) Regulation, 2015, we would like to inform you that at the meeting of Board of Directors of M/s Phyto Chem (India) Limited held on 08th August 2022, the Board has approved inter-alia the following items: 1. Approved the Unaudited Financial Results of the company for the First Quarter ended 30th June 2022. 2. Approved the appointment of M/s. Vijendra & Co., Company Secretaries as Secretarial Auditors of the Company for the Financial Year 2022-23. 3. Approved the Directors' Report and Report on Corporate Governance for the year 2021-22. 4. Approved the Notice of 33rd Annual General Meeting of the Company. 5. Approved the proposal of Rights issue of the Company. 6. Approved the appointment of M/s. T. Adinarayana & Co, Chartered Accountants, Hyderabad (FRN: 000041S) as Tax Auditors of the Company for the Financial Year 2021-22 (Assessment Year 2022-23). The meeting commenced at 04:30 P.M. and concluded at 06:45 P.M.

PHYTO CHEM (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2022 ,inter alia, to consider and approve We wish to inform you that the meeting of the Board of Directors of the Company will be held on Monday the 08th day of August 2022 at 04:30 P.M. at the Corporate Office No. 8-3-229/23, First Floor, Thaherville, Yousufguda Checkpost, Hyderabad - 500 045, 'inter-alia' to consider and take on record the unaudited Financial Results of the Company for the First Quarter ended 30th June 2022. In this connection, as per the Company's Code of Conduct for Prohibition of Insider Trading, the "Trading Window" for dealing in the securities of the Company is closed for all the Directors/ Officers/ Designated Employees of the Company from 01-07-2022 and will open after 48 hours of the announcement and intimation of the Results by the Company to the Stock Exchange on 08-08-2022. This communication has already been circulated to all the Directors/ Officers/ Designated Employees of the Company.

Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 and based on the certificate received from M/s. Bigshare Services Pvt. Ltd. (Registrar and Share Transfer Agent), we hereby confirm that the securities received for dematerialization have been mutilated and cancelled after due verification and the name of the respective depository has been updated in the records as the registered owner within the stipulated time of receipt of certificate of security. Further, the certificates of securities which were dematerialized are listed on the Stock Exchange(s) where the earlier issued securities are listed. This is for your information and record.

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- YARLAGADDA JANAKI RAMAIAH Designation :- Any Other

We wish to inform you that, in accordance with the Code of Conduct for Prevention of Insider Trading devised by the Company, as per the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in the shares of the Company is closed to all the Directors, Key Managerial Personnel and all designated persons of the Company with effect from 1st July 2022 till 48 hours after the declaration of Quarterly Unaudited Financial Results of the Company for the First quarter ended on 30th June 2022. The date of Board Meeting for the consideration of Unaudited Financial Results of the Company for the First quarter ended on 30th June 2022 shall be intimated in due course of time. You are requested to kindly take the same on record for your information and request you to acknowledge the receipt of above.

Pursuant to Regulation 23(9) of Listing Regulations, please find enclosed disclosure of related party transactions on a consolidated basis for the half year ended March 31, 2022. This is for your information and record.

Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular no. CIR/CFD/CMD1/27/2019 dated February 08, 2019, please find attached Annual Secretarial Compliance Report of Phyto Chem (India) Limited for the financial year ended March 31, 2022. Kindly take this information on record.

In furtherance to the Board Meeting Notice dated 19th May 2022, we wish to inform you that at the meeting of Board of Directors of M/s Phyto Chem (India) Ltd. held today i.e., on 28th May 2022, the Board has considered and approved the Audited Financials for the Fourth quarter and year ended 31st March 2022. The said Audited Financial Results were reviewed by the Audit Committee and thereafter approved by the Board. Pursuant to Regulation 33 of the SEBI (LODR) Regulations, 2015, statement showing the Audited Financial Results for the Fourth Quarter & Year ended 31st March 2022 along with the statement of Assets & Liabilities, Cash Flow statement and Auditor's Report of the Statutory Auditors are enclosed herewith. Pursuant to Regulation 33 (3) (d) of the SEBI (LODR) Regulations, 2015, the Board declares that the above said Auditor's Reports are with unmodified opinion with respect to the Audited Financial Results for the Fourth Quarter & Year ended 31st March 2022.

Pursuant to the provisions of Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, we would like to inform you that at the meeting of Board of Directors of M/s Phyto Chem (India) Limited held today i.e., on 28th May, 2022, the Board has approved inter-alia the following items: 1. Approval of the Audited Financial Results of the Company for the Fourth Quarter ended and Year ended 31st March, 2022. 2. Appointment of M/s R. B. Associates., Chartered Accountants as the Internal Auditors of the Company for the Financial Year 2021-22. 3. Approval for availment of unsecured loans from Non-Banking Financial Companies and Directors of the Company. 4. Approval for manufacturing and marketing of Ferro alloy metal Products. The meeting commenced at 02:00 P.M. and concluded at 10:40 P.M. This is for your information and record.